Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Filings indexed 442 across all filing types
Latest filing 2022-03-21 Major Shareholding Noti…
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an entity acquires or changes its stake in a company beyond a certain threshold (typically 5%). In the context of global financial reporting, this is classified as a 'Major Shareholding Notification' (MRQ), as it details the reporting entity's (SangSangIn Savings Bank) interest in the issuer (Intromedic) due to collateral disposal rights.
2022-03-21 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to notify the market when an entity's shareholding in a listed company crosses certain thresholds (typically 5%). According to the provided definitions, this falls under 'Major Shareholding Notification'.
2022-03-21 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding a shareholder meeting, including the purpose of the meeting, voting procedures, and financial statements (balance sheets, income statements) provided for shareholder review. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-16 Korean
주권매매거래정지(풍문 또는 보도 관련)
Delisting Announcement Classification · 100% confidence The document is a short, formal regulatory notice regarding the suspension of stock trading for Intromedic due to rumors or reports. It cites specific KOSDAQ market regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding market activity rather than a financial report or specific corporate action like a dividend or director dealing, it falls under the general regulatory filing category.
2022-03-14 Korean
조회공시요구(풍문또는보도)(감사의견 비적정설)
Regulatory Filings Classification · 100% confidence The document is a formal request from a regulatory body (exchange) to the company 'Intromedic' regarding rumors or reports about a 'non-appropriate audit opinion'. This is a standard regulatory inquiry/announcement issued by an exchange to a listed company, which falls under the general regulatory filing category.
2022-03-14 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) and a subsequent amendment (정정신고) regarding the agenda items for the meeting. It provides details on the date, location, and specific resolutions to be voted upon, such as financial statement approval, director appointments, and remuneration limits. This type of document is standard for proxy solicitation and shareholder meeting information, falling under the Proxy Solicitation & Information Statement category.
2022-03-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.